The following government grants in the FederalGrants.com database contain the term small business in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Announcement of Availability of Funds for Replication of Programs Proven Effective through Rigorous Evaluation to Reduce Teenage Pregnancy, Behavioral Risk Factors Underlying Teenage Pregnancy, or Other Associated Risk |
93.297 |
AH-TP1-19-001 |
| Research and Evaluation on Drugs and Crime, FY 2019 |
16.560 |
NIJ-2019-15444 |
| Rehabilitation Research and Training Center (RRTC) on Transition to Employment for Youth and Young Adults with Serious Mental Health Conditions |
93.433 |
HHS-2019-ACL-NIDILRR-RTEM-0334 |
| Rehabilitation Research and Training Center (RRTC) on Community Living and Participation For Youth And Young Adults with Serious Mental Health Conditions |
93.433 |
HHS-2019-ACL-NIDILRR-RTCP-0333 |
| HQ NWRS System Enhancements |
15.654 |
F19AS00099 |
| Quantum Information Science Enabled Discovery (QuantISED) for High Energy Physics |
81.049 |
DE-FOA-0002077 |
| Community Connect Grant Program |
10.863 |
RDRUS-CC-2019 |
| Initiative to Maximize Research Education in Genomics: Courses (R25 Clinical Trial Not Allowed) |
93.172 |
PAR-19-185 |
| Women's Business Center - Initial Phase Grant |
59.043 |
OWBO-2019-01-1 |
| BJA FY 19 Adult Drug Court and Veterans Treatment Court Planning, Training, Technical Assistance, and Resource Center Initiative |
16.585 |
BJA-2019-15086 |
| Research and Evaluation on Terrorism Prevention, FY 2019 |
16.560 |
NIJ-2019-15303 |
| Research into Desistance from Crime, FY 2019 |
16.560 |
NIJ-2019-15527 |
| Bioequivalence of Topical Products: Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Not Allowed) |
93.103 |
RFA-FD-19-010 |
| Bioequivalence of Topical Products: Elucidating the Sensorial and Functional Characteristics of Compositionally Different Topical Formulations (U01 Clinical Trial Required) |
93.103 |
RFA-FD-19-009 |
| FY2019 Research Opportunities in Accelerator Stewardship |
81.049 |
DE-FOA-0002069 |
| Rehabilitation Engineering Research Centers (RERC) Program: RERC on Information and Communication Technologies Access |
93.433 |
HHS-2019-ACL-NIDILRR-REGE-0336 |
| Rehabilitation Research and Training Center (RRTC) on Improving Employment Outcomes for People with Psychiatric Disabilities |
93.433 |
HHS-2019-ACL-NIDILRR-RTEM-0337 |
| Functional RNA Modifications Environment and Disease (FRAMED) (R01 Clinical Trial Not Allowed) |
93.113 |
RFA-ES-19-001 |
| Centers for Medical Countermeasures Against Radiation Consortium (U19 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-19-012 |
| Integrated Care for Kids (InCK) |
93.378 |
CMS-2B2-20-001 |
| Innovative Approaches for Improving Environmental Health Literacy (R43/R44 Clinical Trial Not Allowed) |
93.113 |
RFA-ES-19-005 |
| Innovative Approaches for Improving Environmental Health Literacy (R41/R42 Clinical Trial Not Allowed) |
93.113 |
RFA-ES-19-006 |
| Functional RNA Modifications Environment and Disease (FRAMED) (R21 Clinical Trial Not Allowed) |
93.113 |
RFA-ES-19-002 |
| Bioequivalence of Topical Products: Bioequivalence Considerations for Ungual, Scalp, Vaginal, Anal or Rectal Dosage Forms (U01 Clinical Trial Not Allowed) |
93.103 |
RFA-FD-19-008 |
| Research and Evaluation on Policing, FY 2019 |
16.560 |
NIJ-2019-15543 |
| Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents: Center Without Walls (PCS-EMA CWOW) (U54 Clinical Trial Not Allowed) |
93.853, 93.865 |
RFA-NS-19-022 |
| One Health Workforce - Next Generation (OHW-NG) |
98.001 |
7200AA19RFA00006 |
| Secondary Data Analysis to Examine Long-Term and/or Potential Cross-Over Effects of Prevention Interventions: What are the Benefits for Preventing Mental Health Disorders? (R01 Clinical Trial Not Allowed) |
93.213, 93.242, 93.313 |
RFA-MH-20-110 |
| Patient Reported Outcomes Tool Development for Use in Non-Cystic Fibrosis Bronchiectasis Clinical Trials (U01- Clinical Trial Required) Activity Code |
93.103 |
RFA-FD-19-014 |
| Great Lakes Restoration Initiative, Partners for Fish and Wildlife Program 2019 |
15.662 |
F19AS00091 |
| Early Head Start Expansion and Early Head Start-Child Care Partnership Grants - Santa Clara County, California |
93.600 |
HHS-2019-ACF-OHS-HP-R09-1593 |
| Early Head Start Grantee -- Santa Clara County, California |
93.600 |
HHS-2019-ACF-OHS-CH-R09-1592 |
| INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.351, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.865, 93.866, 93.867 |
RFA-OD-19-015 |
| Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trials Required) |
93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.307, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.853, 93.865, 93.866, 93.867 |
RFA-OD-19-018 |
| Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.351, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.855, 93.865, 93.866, 93.867 |
RFA-OD-19-016 |
| Biology of Bladder Cancer (R01 Clinical Trial Optional) |
93.393, 93.396 |
PAR-19-183 |
| Research and Evaluation on the Administration of Justice, FY 2019 |
16.560 |
NIJ-2019-15645 |
| Biology of Bladder Cancer (R21 Clinical Trial Optional) |
93.393, 93.396 |
PAR-19-184 |
| Refinement and Testing of Interventions to Sustain ADHD Treatment Effects Across Settings and Developmental Transitions (R34 Clinical Trial Required) |
93.242 |
RFA-MH-20-100 |
| NCI Awardee Skills Development Consortium: Program Logistics and Evaluation Coordinating Center (U24 Clinical Trial Not Allowed) |
93.398 |
RFA-CA-19-011 |
Search Results 5841-5880 of 21019
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 [Next] |
